about
Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System.Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis.Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.Neuroendocrine liver metastasis: The chance to be cured after liver surgery.The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis.The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysisA multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma.Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis.Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy.Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults: A Multi-institutional Analysis.Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma.Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor.Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.Intrahepatic clear cell cholangiocarcinoma - An uncommon histologic subtype: case report and literature review.Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis.Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis.Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma.Updates and Critical Insights on Glissonian Approach in Liver Surgery.A Fair Chance for Everyone: Total Tumor Volume as a Selection Tool in Liver Transplantation for Hepatocellular Carcinoma.The Comprehensive Complication Index (CCI®) is a Novel Cost Assessment Tool for Surgical ProceduresPeri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved
P50
Q30252389-6393EEF7-319D-4F7F-9462-1D0098DCF995Q30252588-BC8BC63A-77D2-4058-99F7-E7423C0BC3BDQ30252624-EC8DB2D4-E0FB-4B7A-9940-F445DFC5AD42Q30274781-579981C5-7E99-4AAD-B18A-AE0FC37CEDE2Q30274866-B8BB72C1-BE01-4FED-84EE-AC55862257B5Q30274956-22A0D7F1-6C68-4ECB-9FF6-C0AECE3E9911Q30276213-8315325E-AC7B-4B02-8B6C-15DB01AC6969Q30276944-4FE3141C-A6AA-4923-932C-FE0031E5E37BQ30277031-4C07F733-9757-4F98-995B-8EA53D06F718Q30278517-03899DB4-80D8-46C0-8DDC-A5A14E65E0B0Q30279208-6515EA1F-6BC1-4C3E-B11B-55F386D0062BQ30300026-9E5D26E5-9F6D-4611-A617-E1DBBD4A65E4Q30300137-93E2EE03-8C5C-4DCB-97BA-4265706270EAQ30300259-655ED561-D33C-4523-93EE-F4863A21E1DCQ30300388-AA27C9B3-D751-41A7-9368-5490E90B45CEQ30360985-0E06506E-DFA0-4014-9665-D474E1F65B9CQ33554179-412DCBF1-8EB7-4646-8F27-F8C09604D236Q38661081-2BF1A0E2-10BE-4F65-A78D-B33C73D97573Q38668755-B0B78F2F-FCD8-4172-9B13-999C2D29D695Q39117222-9AC38856-A9CD-45F3-9C18-E35C0ED992CFQ40499240-BCA14F7B-5D30-4D47-BDC7-2086525A7195Q41492478-E00D3965-D437-453F-BB71-4D0759C0C001Q45063804-4234E487-4DA6-4DB5-8A5B-0FBCDEAF8E51Q45064136-7697DFCC-DF06-4597-9E4E-ADD469DF5BF7Q45066722-C51DFBED-E108-499D-9BDE-16E1EC64FA97Q45068870-54758E3D-03E9-4CAA-8614-26A3AC3F767DQ47173104-69B82C69-5B83-477C-B989-D9B6DB428E04Q47860447-42ED5450-3384-436B-9E68-3CD5275E4613Q49963087-432776A1-F507-40DD-9823-5B1175659B36Q57067939-FA95348B-9E62-4FEE-A487-CD12ECE3ED27Q82418582-53F6D55C-6EDD-4D9F-97E6-3F546777DC26Q88151679-2CFF2804-E2B3-4A7B-AE63-04AA67501200
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hugo P Marques
@ast
Hugo P Marques
@en
Hugo P Marques
@es
Hugo P Marques
@nl
type
label
Hugo P Marques
@ast
Hugo P Marques
@en
Hugo P Marques
@es
Hugo P Marques
@nl
prefLabel
Hugo P Marques
@ast
Hugo P Marques
@en
Hugo P Marques
@es
Hugo P Marques
@nl
P106
P1153
24537571800
P21
P31
P496
0000-0003-3540-0488